SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Nearly 16% of American adults—that's close to one in six—now has diabetes, according to the latest data from the U.S. Centers ...

But it does not mean people without diabetes can't experience it. Prediabetics, people who eat carbohydrate-rich foods or those who wait too long between meals may even suffer low blood sugar levels.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.